Back to results
RecruitingPhase 2

Combined Immunotherapies in Metastatic ER+ Breast Cancer

NCT04563507

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Weill Cornell Medicine

New York, New York, United States

+2 additional locations

Contact

Fabiana Gregucci, M.D.

646-962-3110fgr4002@med.cornell.edu
View on ClinicalTrials.gov
Combined Immunotherapies in Metastatic ER+ Breast Cancer — TrialFind